Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement

Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement

COVID-19 is a devastating respiratory and inflammatory illness caused by a new coronavirus that is rapidly spreading throughout the human population. Over the past 12 months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has already infected over 1...

Full description

Bibliographic Details
Main Authors: Mathew A. Coban, Juliet Morrison, Sushila Maharjan, David Hyram Hernandez Medina, Wanlu Li, Yu Shrike Zhang, William D. Freeman, Evette S. Radisky, Karine G. Le Roch, Carla M. Weisend, Hideki Ebihara, Thomas R. Caulfield
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Biomolecules
Subjects:
COVID
drug discovery
multi-drug therapy
bioprinting
Online Access:https://www.mdpi.com/2218-273X/11/6/787

Internet

https://www.mdpi.com/2218-273X/11/6/787

Similar Items